Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin-related protein 10 (ACTR10) is a cytoskeletal protein encoded by the ACTR10 gene in humans, belonging to the actin-related protein family[1][2][3][5]. It serves as a component of the dynactin complex, which is essential for activation of the motor protein dynein and is thus involved in microtubule-based transport within cells, specifically supporting retrograde axonal transport of mitochondria and other vesicles in neurons[1][2][5]. It participates in cytoskeletal organization and is predicted to be found mainly in the cytosol, extracellular region, and secretory granule[1][2][5]. ACTR10 has been identified as a regulatory or structural protein that may be involved in multifaceted cellular functions such as neuronal connectivity, immune responses, and maintenance of cellular homeostasis[1]. Dysregulation of ACTR10 has been associated with immune-related changes in diseases such as Alzheimer’s disease and with Charcot-Marie-Tooth disease, axonal type 2O[1][2]. However, there are no known drugs directly targeting ACTR10, and it is not currently classified as a direct therapeutic target[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin-related protein 10 (ACTR10).